Analyst Ratings February 12, 2026

Citizens Cuts Pegasystems Target to $58 Citing Slower Growth, Keeps Outperform Rating

Analyst reaction follows mixed fourth-quarter 2025 results that beat expectations but showed signs of deceleration

By Avery Klein PEGA
Citizens Cuts Pegasystems Target to $58 Citing Slower Growth, Keeps Outperform Rating
PEGA

Citizens lowered its price objective on Pegasystems to $58 from $78 while retaining a Market Outperform rating after the company’s fourth-quarter 2025 results. Pegasystems beat consensus on revenue and non-GAAP EPS, and reported rising annual contract value and stronger-than-expected free cash flow, but a modest slowdown in constant-currency growth and a sharp share-price drop prompted analyst reevaluation. Barclays separately upgraded the stock to Overweight with a $48 target, highlighting the company's role in complex business process software.

Key Points

  • Citizens lowered its Pegasystems price target to $58 from $78 but maintained a Market Outperform rating.
  • Pegasystems beat consensus with $0.76 non-GAAP EPS and $504 million in revenue; total annual contract value rose to $1.608 billion.
  • Despite beats, constant-currency ARR growth decelerated to 13.8% from 14.1%, and the stock fell about 12% after the results.

Citizens reduced its price target on Pegasystems Inc. to $58.00 from $78.00 on Thursday, but kept a Market Outperform rating on the enterprise software vendor.

The adjustment follows Pegasystems’ fourth-quarter 2025 earnings report, released Tuesday after the market close, which produced results that outpaced analyst forecasts but revealed some signs of slowing momentum.

Pega reported non-GAAP earnings per share of $0.76, slightly above the Street expectation of $0.73. Revenue came in at $504 million versus a consensus figure of $492 million, representing about 3% year-over-year growth.

Annual contract value for the company reached $1.608 billion, topping the $1.573 billion consensus and marking a 17% increase from a year earlier. On a constant-currency basis, however, ARR growth slowed to 13.8%, down from 14.1% in the prior quarter.

Free cash flow was stronger than expected as well, with Pegasystems generating $152 million against a consensus estimate of $111 million. Despite those upside surprises on earnings, revenue and cash generation, the stock tumbled roughly 12% immediately after the earnings release, widening its year-to-date decline to around 36% while the Russell 3000 has risen approximately 2% over the same period.

In a separate move, Barclays raised its rating on Pegasystems from Equalweight to Overweight and set a $48.00 price target. Barclays cited the company’s competitive position in complex business process software and said the segment is unlikely to see significant disruption from generative AI in the foreseeable future.

The mix of upside beats and signs of deceleration appears to have driven divergent analyst responses: Citizens trimmed its target substantially but held to a Market Outperform stance, while Barclays upgraded its view and set a lower target than Citizens’ revised level. The market reaction suggests investors prioritized the company’s moderating growth trend and the immediate earning-period volatility over the topline and cash-flow beats.


Market implications

  • The reaction highlights investor sensitivity to growth trajectory and quarter-to-quarter deceleration even when headline earnings and cash flow beat expectations.
  • Analyst positioning remains mixed, with at least one firm raising its rating while another reduced its price objective and retained an outperform view.
  • Enterprise software and broader software sector sentiment may be affected by how investors interpret growth deceleration versus cash flow strength.

Risks

  • Decelerating constant-currency growth could pressure future revenue momentum and investor confidence - impacts enterprise software and tech sector sentiment.
  • Sharp share-price declines despite beating estimates highlight the risk of volatility and negative market reaction to growth signals - impacts equity investors and stock performance.
  • Divergent analyst views and differing price targets introduce uncertainty about near-term valuation and investor expectations for the company.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026